Please anonymize the following text: 



Record date: 2088-01-06

CC: f/up of HTN and DM management



HPI: 59 yo female who presents back to clinic with her

daughter reporting that she needs medical clearance for

eye surgery and cardiac testing had been ordered at HDC

but she was unable to go.  Denies any CP.  DOE at baseline.

Brings in her machine log showing FS's in AM 101-238

with most values in 100's.  FS's in PM 92-235.  Reports

no symptoms of hyperglycemia except fatigue.  Ongoing

numbness and tingling in her LE's.  11/25 A1C 9.1, TChol 232.

Has been started on Lipitor 10 mg po qd and Vit D 50,000

1 cap weekly by Dr. Yap at MS.  Glyburide

increased to BID.  Reports injecting insulin daily as directed.

No prior auth yet for her Cozaar which she is now out of.



================ Problems ================

Menopause at age 52          

H/O R sided sciatica          

H/O pneumonia 1/2082          

S/P vocal cord cyst removal          

S/P cholecystectomy          

S/P C section x 2          

Diabetes since '67          

Severe nonproliferative diabetic retinopathy with severe macular edema          

H/O pyelonephritis          



================ Medications ================

ATENOLOL 100 MG (100MG TABLET  take 1  ) PO  QD 

COZAAR (LOSARTAN)   100MG TABLET  take 1  PO  QD 

DARVOCET N 100 (PROPOXYPHENE NAP/ACETAMIN... 1 TAB   PO  BID PRN pain

ECASA (ASPIRIN ENTERIC COATED)   81MG TABLET EC       take 1 Tablet(s) PO  QD 

GLYBURIDE 5 MG (5MG TABLET  take 1  ) PO  BID 

IBUPROFEN 600 MG (600MG TABLET  take 1  ) PO  BID PRN 

LANTUS (INSULIN GLARGINE) 84 UNITS   SC  QAM 

LASIX (FUROSEMIDE) 20 MG (20MG TABLET  take 1  ) PO  QD 

LIPITOR (ATORVASTATIN) 10 MG (10MG TABLET  take 1  ) PO  QD 

NORTRIPTYLINE (NORTRIPTYLINE HCL) 25 MG (25MG CAPSULE  take 1  ) PO  QHS 

PAXIL (PAROXETINE)   20MG TABLET    take 1 Tablet(s) PO  QD 

PROTONIX (PANTOPRAZOLE) 40 MG    PO  QD 

TYLENOL #2 (ACETAMINOPHEN W/CODEINE 15MG) 1 TAB   PO  BID 



================ Allergies ================

NKA: 				



PEx: VS: Wt 183, BP 145/84, P 64 regular, T 98.8

WDWN older female in NAD.  HEENT: anicteric sclerae  

Neck: supple, no JVD.  

Lungs: CTA.  CV: RRR, s1s2, nl, II/VI SEM at LSB  

Abd: soft, NT  

Ext: no c/c/1+ bil edema.  No foot ulcerations.



EKG: NSR at 63, 0.16/0.12/0.47, +RBBB



A/P:

1. HTN.  Mildly elevated in setting of not having Cozaar.

Prior auth requested, will use Norvasc 2.5 mg po qd

in addition to Lasix and Atenolol until Cozaar approved,

samples given to patient.  Dietary and exercise rec's reviewed.

2. DM, stable, Glyburide increased at MS.  Dietary rec's

reviewed.

3. r/o CAD, patient unable to run given chronic joint pains

and diabetic neuropathy, will schedule for pharmacologic

stress MIBI for presurgical cardiac clearance.  Will follow.

f/up appt given.

4. Diabetic neuropathy, worsening, f/up at Montefiore Springs.



Singh, M.D.



1. F/C/O: 59 yo female who presents back to clinic with her

daughter reporting that she needs medical clearance for

eye surgery and cardiac testing had been ordered at HDC

but she was unable to go.  Denies any CP.  DOE at baseline. 

2. Brings in her machine log showing FS's in AM 101-238

with most values in 100's.  FS's in PM 92-235.  Reports

no symptoms of hyperglycemia except fatigue.  Ongoing

numbness and tingling in her LE's.  11/25 A1C 9.1, TChol 232. 

3. Has been started on Lipitor 10 mg po qd and Vit D 50,000 

1 cap weekly by Dr. Yap at MS.  Glyburide increased to BID.  Reports

injecting insulin daily as directed.  No prior auth yet for her Cozaar which she is now out of.

4.  Menopause at age 52          

H/O R sided sciatica          

H/O pneumonia 1/2082          

S/P vocal cord cyst removal          

S/P cholecystectomy          

S/P C section x 2          

Diabetes since '67          

Severe nonproliferative diabetic retinopathy with severe macular edema          

H/O pyelonephritis          



5.  Medications

ATENOLOL 100 MG (100MG TABLET  take 1  ) PO  QD 

COZAAR (LOSARTAN)   100MG TABLET  take 1  PO  QD 

DARVOCET N 100 (PROPOXYPHENE NAP/ACETAMIN... 1 TAB   PO  BID PRN pain

ECASA (ASPIRIN ENTERIC COATED)   81MG TABLET EC       take 1 Tablet(s) PO  QD 

GLYBURIDE 5 MG (5MG TABLET  take 1  ) PO  BID 

IBUPROFEN 600 MG (600MG TABLET  take 1  ) PO  BID PRN 

LANTUS (INSULIN GLARGINE) 84 UNITS   SC  QAM 

LASIX (FUROSEMIDE) 20 MG (20MG TABLET  take 1  ) PO  QD 

LIPITOR (ATORVASTATIN) 10 MG (10MG TABLET  take 1  ) PO  QD 

NORTRIPTYLINE (NORTRIPTYLINE HCL) 25 MG (25MG CAPSULE  take 1  ) PO  QHS 

PAXIL (PAROXETINE)   20MG TABLET    take 1 Tablet(s) PO  QD 

PROTONIX (PANTOPRAZOLE) 40 MG    PO  QD 

TYLENOL #2 (ACETAMINOPHEN W/CODEINE 15MG) 1 TAB   PO  BID 



================ Allergies ================

NKA:



PEx: VS: Wt 183, BP 145/84, P 64 regular, T 98.8

WDWN older female in NAD.  HEENT: anicteric sclerae  

Neck: supple, no JVD.  

Lungs: CAT.  CV: RRRR, s1s2, nl, II/VI SEM at LSB  

Abd: soft, NT  

Ext: no c/cold,  bil edema.  No foot ulcerations.











PEx: VS:	Pax: Prostat 200MG: 


Prostat: 19 



NK: 59 





























12 weeks 














1




































and

100/10012





10
12


























and sympt

10-week
20


2
A2 days.








and 11.
20 10 0



and:
.







within and take.

202092.



and 

3 





and and 
 20, 4





.
.
 12. The last 4

the 4/2 days.
.
[ 12.

 and 8 and 11. to  date and to go.  to date.
, 1.
 and.
. (2.
.
2.
A1
2.
.
:
and and the following, and the: The date and the 190, last (110. 1 (1. The,10, a, and: 0 ( 1
 for 1M1 for yife
 (last
.
: the for:  for  for the. ientical (31 week. a and.
 the day. (1 and the:
. the. : 1 year (1:  date, 1,112.
 for "  and for the patient 10 for the 2 (1,2, a and year (2: :  and  (0 the and the.1  for  and for it for: the in  for it and.  (2, for the, a in a, a in 20 in the last.  for a, the is, the and for it for "2 and  (1.  and..1 :  1 and a as (1: a 2 and 0, the 210. 0 and A, 2112 and 12. 1 (0 ( 0 (2-1 year in year, last with, for for 1, the in the " and a she.  for she in the and and.
.. 0 (2 and,  (2-1 (1 to make to the to any and ( to last andness, 10 and 2 5 ( 0 1 (  and a last a 0-3 and,10.. 01. or 00- and. [ to the and in the, 0  for (1 for the for " for the and and in. the for the for and in the,  to  to  and and for she 0 in ( 0 0 insh (1 ( in a,. and, l to a.,1.: a,, [ and: a, in the in the to a- a:,  in a: an ( An An R for (1- an in a in. in the and [[. (1 in  for the: an  an  (1 in for the in for the and: and- for a in [[ [  for the  to- [[ for ( [ and ( for and [[, [ ( in the to: the in ( [ and to [: and to, to ( to and to to [ to and to the and-c and [  in to ( [ to in in for for [ and ( in [ R  and [: the (-. (- H ( in, and in., and  C in the  and., (  and H and "0 - and ( for for-  and- I day 1 I and PO ( for, in and and ( c to C to to to and to to to- PO H PO- R C and H: [ " and C and, and. and -  and "1 in (1 in- L1- CH1 in in CH in [, C CH, CH C to to to H to S ( ( to and S and and with PO for M in for and and and (,, H- S M for I for H M I H C I I C H I I and I I Ic in C in in for in in to in to. for to. and to in in  in S in and I and H ( ( in and and M ( M in M and M M and for  for M I CF  in and I C CF.. CH S to to.  to to H to to to to H to M to to to to to CH ( to H to to C to to to to [ to to  H m  m H C  N I H C CF I H H C to C  to and to  to H to H CH to CH to [ I  ( and H, C,., and H, M ( to  to to [  (  M  C M and M [ C and, I C: and in: ( CH I/ IN  I C I C to [1 IN: C to C1 to  in H: M. S to and to to. M M ( C C  IN C IN M C CF M ML PO CF  C PO H C and  M to for I and I S H C R CP H C. and C C1 H0 C H H to to to to to to to " to to " ( and to. to H M L and ( M M and [ M M M H M M H L to H M to I and  and L H and and  and I L and S M. I and and H H C H and L C H I H I B Cl and C and C  I Cl In H C Cl C. C. C to L C and I to. H I and H C H C T - to ( C C to H0 to C to [ to and  for and H  H for a C H, H H M ( H and to and M C1 M. C to to to to. to M H H H C2 to M to to H H. M I C to m. M [50 M I1 C. H011111 I H M H M1 H C and I H C H1 H H to for H I C ( C H. I H for to to C to to and to to to to to to PO to to to I. to  H M1 I C. H H C C I ( C M1 C PO M H H H and  A PO.. C M and H M. C ML C C and C C H M M to C to to M to M to H H H PO H C M. and MC M and PO a [ [ [ C. H C- M C H H H H M C I H ( H H H C T H. C M C to M to C to and H H. and H C M and (. M. M. C C M C M C. M C ( C M C to H H.  H  C H [ H c H C C. ( C to [ to C M to to M M M M M  M M M M P M M (. ( M C. H M M M M I M H H M C M C H H M H and  [ C H ( M.. M C M C M  to H T to  H: H M. ( H C ( M:, H. M M M for and and H M H,, M M